Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac 1% gel in knee osteoarthritis
2009-011785-28Phase 3Active
- Sponsor
- SUBSTIPHARM DEVELOPPEMENT
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of diclofenac in knee osteoarthritis (OA) (3 arms), sponsored by SUBSTIPHARM DEVELOPPEMENT. Primary endpoint: Primary efficacy endpoint. Started Aug 2009; status: active.
02
Drugs
diclofenac
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2009-011785-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011785-28.